| Rank | Stock | Price | Rev. Gr. | Dist. 52WH | Perf. 20D |
|---|---|---|---|---|---|
| WKN | Symbol | EPS Growth | Rel. Strength | |||
| 1 | Verisk Analytics | 278.09 $ | 26.37 % | 9.32 % | -3.45 % |
| A0YA2M | VRSK | 88.86 % | 86 | |||
| 2 | Palomar Holdings | 130.13 $ | 40.22 % | 9.49 % | -0.24 % |
| A2PHB6 | PLMR | 49.48 % | 96 | |||
| 3 | HCI Group | 137.14 $ | 49.16 % | 9.70 % | -1.56 % |
| A1W02H | HCI | 199.39 % | 85 | |||
| 4 | Progressive | 259.68 $ | 22.67 % | 11.37 % | -6.44 % |
| 865496 | PGR | 198.70 % | 88 | |||
| 5 | Universal Technical Institute | 26.47 $ | 20.63 % | 13.39 % | -1.64 % |
| 590097 | UTI | 533.33 % | 96 | |||
| 6 | Halozyme Therapeutics | 56.53 $ | 21.35 % | 14.34 % | -7.15 % |
| A0DLHS | HALO | 60.73 % | 92 | |||
| 7 | Insulet | 246.49 $ | 27.42 % | 14.84 % | -0.76 % |
| A0MQX8 | PODD | 250.00 % | 92 | |||
| 8 | Interdigital | 192.19 $ | 28.53 % | 17.15 % | -9.55 % |
| A0MWY3 | IDCC | 41.33 % | 98 | |||
| 9 | Tradeweb Markets | 122.34 $ | 29.44 % | 19.86 % | -8.22 % |
| TW | 20.69 % | 84 | |||
| 10 | Catalyst Pharmaceuticals | 20.86 $ | 32.17 % | 20.27 % | -1.62 % |
| A0LCUL | CPRX | 111.86 % | 90 |
| Insulet | |
|---|---|
| 5-year chart | |
| Mkt. cap. | 16.65 B USD |
| P/S 25 | 6.15 |
| P/S 26 | 5.04 |
| P/E 25 | 68.00 |
| P/E 26 | 37.25 |
Insulet Corp. (PODD) specializes in providing solutions for people with diabetes and aims to fundamentally improve the lives of patients through continuous and automated insulin delivery. Instead of relying on traditional pumps with cumbersome tubes, Insulet offers a compact, portable system that is...
